(Q60678678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

M Terenziani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R Demicheli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C Brambilla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

L Ferrari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Moliterni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Zambetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C Martini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

G Bonadonna

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

English

0 references

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

285-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

Phase-II study of Navelbine in advanced breast cancer

20 October 2019

cites work

1 reference

12 December 2020

Multidrug resistance in cancer chemotherapy

1 reference

12 December 2020

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma

1 reference

12 December 2020

In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence

1 reference

12 December 2020

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

12 December 2020

Navelbine: a new step in cancer therapy?

1 reference

12 December 2020

Survival of patients with metastatic breast cancer diagnosed between 1955 and 1980.

1 reference

12 December 2020

Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer

1 reference

12 December 2020

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

12 December 2020

Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease

1 reference

12 December 2020

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

1 reference

12 December 2020

Safety and tolerance of Navelbine in phase I-II clinical studies

1 reference

12 December 2020

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01806156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8877008%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference